| Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma BS Lee, DI Park, DH Lee, JE Lee, M Yeo, YH Park, DS Lim, W Choi, ... Biochemical and biophysical research communications 491 (2), 493-499, 2017 | 163 | 2017 |
| YAP/TAZ initiates gastric tumorigenesis via upregulation of MYC W Choi, J Kim, J Park, DH Lee, D Hwang, JH Kim, H Ashktorab, DT Smoot, ... Cancer research 78 (12), 3306-3320, 2018 | 137 | 2018 |
| Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer JE Hwang, JY Hong, K Kim, SH Kim, WY Choi, MJ Kim, SH Jung, HJ Shim, ... BMC cancer 13, 1-8, 2013 | 78 | 2013 |
| Therapeutic targeting of DNA damage response in cancer W Choi, ES Lee International journal of molecular sciences 23 (3), 1701, 2022 | 66 | 2022 |
| A comprehensive and comparative review of global gastric cancer treatment guidelines SS Eom, W Choi, BW Eom, SH Park, SJ Kim, YI Kim, HM Yoon, JY Lee, ... Journal of Gastric Cancer 22 (1), 3, 2022 | 60 | 2022 |
| YAP and AP-1 cooperate to initiate pancreatic cancer development from ductal cells in mice J Park, D Eisenbarth, W Choi, H Kim, C Choi, D Lee, DS Lim Cancer research 80 (21), 4768-4779, 2020 | 42 | 2020 |
| Gal-3BP negatively regulates NF-κB signaling by inhibiting the activation of TAK1 CS Hong, MR Park, EG Sun, W Choi, JE Hwang, WK Bae, JH Rhee, ... Frontiers in immunology 10, 1760, 2019 | 36 | 2019 |
| Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial W Choi, JG Kim, SH Beom, JE Hwang, HJ Shim, SH Cho, MH Shin, ... Cancer Research and Treatment 52 (1), 246-253, 2020 | 26 | 2020 |
| Exploring connections between oral microbiota, short-chain fatty acids, and specific cancer types: a study of oral cancer, head and neck cancer, pancreatic cancer, and gastric … Z Nouri, SW Choi, IJ Choi, KW Ryu, SM Woo, SJ Park, WJ Lee, W Choi, ... Cancers 15 (11), 2898, 2023 | 25 | 2023 |
| Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapy DE Kim, UJ Kim, WY Choi, MY Kim, SH Kim, MJ Kim, HJ Shim, JE Hwang, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2013 | 25 | 2013 |
| Genomic instability of circulating tumor DNA as a prognostic marker for pancreatic cancer survival: a prospective cohort study SM Woo, MK Kim, B Park, EH Cho, TR Lee, CS Ki, KA Yoon, YH Kim, ... Cancers 13 (21), 5466, 2021 | 16 | 2021 |
| Drug rash induced by levothyroxine tablets. YH Choi, WY Choi, HC Kang, YI Koh, EH Bae, SW Kim Thyroid 22 (10), 2012 | 13 | 2012 |
| Establishment of patient-derived organoids using ascitic or pleural fluid from cancer patients W Choi, YH Kim, SM Woo, Y Yu, MR Lee, WJ Lee, JW Chun, SH Sim, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2023 | 12 | 2023 |
| The clinical impact of capmatinib in the treatment of advanced non-small cell lung cancer with MET exon 14 skipping mutation or gene amplification W Choi, SY Park, Y Lee, KY Lim, M Park, GK Lee, JY Han Cancer res treat 53 (4), 1024-1032, 2021 | 11 | 2021 |
| A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis W Choi, Y Cho, SY Park, KH Hwang, JY Han, Y Lee Journal of Cancer Research and Clinical Oncology 147, 213-222, 2021 | 10 | 2021 |
| Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors W Choi, Y Lee, BK Choi, BM Park, YH Kim, T Yun, WJ Lee, H Yoo, ... Cytotherapy 25 (11), 1236-1241, 2023 | 4 | 2023 |
| MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report W Choi, KC Jeong, SY Park, S Kim, EH Kang, M Hwang, JY Han Translational Lung Cancer Research 11 (9), 1967, 2022 | 4 | 2022 |
| Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies JG Park, BK Choi, Y Lee, EJ Jang, SM Woo, JH Lee, KH Kim, H Hwang, ... EPMA Journal 12, 629-645, 2021 | 4 | 2021 |
| Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event EA Cho, WY Choi, SH Kim, JY Hong, SH Jung, MJ Kim, JE Hwang, ... Journal of Chemotherapy 26 (4), 248-252, 2014 | 4 | 2014 |
| Korean practice guidelines for gastric cancer 2024: an evidence-based, multidisciplinary approach (update of 2022 guideline) IH Kim, SJ Kang, W Choi, AN Seo, BW Eom, B Kang, BJ Kim, BH Min, ... Journal of Gastric Cancer 25 (1), 5, 2025 | 3 | 2025 |
